Catherine John

517 total citations
20 papers, 377 citations indexed

About

Catherine John is a scholar working on Endocrine and Autonomic Systems, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Catherine John has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Endocrine and Autonomic Systems, 4 papers in Pharmacology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Catherine John's work include Regulation of Appetite and Obesity (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and BRCA gene mutations in cancer (3 papers). Catherine John is often cited by papers focused on Regulation of Appetite and Obesity (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers) and BRCA gene mutations in cancer (3 papers). Catherine John collaborates with scholars based in United States, China and Tanzania. Catherine John's co-authors include Bruce M. Cohen, Döst Öngür, William A. Carlezon, Paul J. Currie, Karen L. Smith, Heinrich S. Gompf, Ashlee Van’t Veer, Anita J. Bechtholt, Elizabeth I. Sypek and Colin D. Chapman and has published in prestigious journals such as The Lancet Oncology, American Journal of Obstetrics and Gynecology and Neuropsychopharmacology.

In The Last Decade

Catherine John

19 papers receiving 374 citations

Peers

Catherine John

CMN

PHARM

PHYSI

Mohammad J. Eslamizade Iran

Yingxu Dong China

Sophie M. Banas France

William Nguyen United States

Nozomi Asaoka Japan

Elif Tunc‐Ozcan United States

Ana Isabel Santos Portugal

Sun Choi United States

Anatoliy V. Gladkevich Netherlands

Aarron Phensy United States

Mohammad J. Eslamizade Iran

Catherine John

140 ×0.8

CMN

78 ×0.7

62 ×0.7

PHARM

86 ×1.3

55 ×0.9

PHYSI

Citations per year, relative to Catherine John Catherine John (= 1×) peers Mohammad J. Eslamizade

Countries citing papers authored by Catherine John

Since Specialization

Citations

This map shows the geographic impact of Catherine John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine John more than expected).

Fields of papers citing papers by Catherine John

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine John. The network helps show where Catherine John may publish in the future.

Co-authorship network of co-authors of Catherine John

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine John. A scholar is included among the top collaborators of Catherine John based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine John. Catherine John is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jiandong, Weimin Kong, Catherine John, et al.. (2025). High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer in vitro and in vivo. International Journal of Biological Sciences. 21(4). 1545–1565. 2 indexed citations

Chen, Shuning, Weimin Kong, Nikita Sinha, et al.. (2025). Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer. Frontiers in Pharmacology. 16. 1520771–1520771.

Kong, Weimin, Boer Deng, Catherine John, et al.. (2024). Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer. Gynecologic Oncology. 191. 116–123. 10 indexed citations

Deng, Boer, Weimin Kong, Ziyi Zhao, et al.. (2023). Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer. Cancers. 15(22). 5407–5407. 14 indexed citations

John, Catherine, Robert T. Jones, Ilana Cass, et al.. (2021). Obesity is associated with poor clinical outcomes in BRCA mutation carriers with epithelial ovarian cancer. Gynecologic Oncology. 162. S215–S215. 1 indexed citations

John, Catherine, Abigail Fong, Rodrigo F. Alban, et al.. (2021). Breast cancer surveillance following ovarian cancer in BRCA mutation carriers. Gynecologic Oncology. 164(1). 202–207. 5 indexed citations

Hersh, Alyssa R., et al.. (2021). Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder. The Journal of Maternal-Fetal & Neonatal Medicine. 35(25). 4918–4926. 5 indexed citations

Fong, Abigail, Ilana Cass, Catherine John, et al.. (2020). Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers. The American Surgeon. 86(10). 1243–1247. 3 indexed citations

Vasselli, Joseph R., et al.. (2017). Central effects of insulin detemir on feeding, body weight, and metabolism in rats. American Journal of Physiology-Endocrinology and Metabolism. 313(5). E613–E621. 6 indexed citations

10.

Amadori, Dino, Patrizia Serra, Lauro Bucchi, et al.. (2016). The Mwanza Cancer Project. The Lancet Oncology. 17(2). 146–148. 22 indexed citations

11.

John, Catherine, et al.. (2016). 777: A cost effectiveness analysis of Buprenorphine vs. Methadone for maintenance of opioid addiction during pregnancy. American Journal of Obstetrics and Gynecology. 216(1). S449–S449. 2 indexed citations

12.

John, Catherine, Elizabeth I. Sypek, William A. Carlezon, et al.. (2015). Blockade of the GLT-1 Transporter in the Central Nucleus of the Amygdala Induces both Anxiety and Depressive-Like Symptoms. Neuropsychopharmacology. 40(7). 1700–1708. 61 indexed citations

13.

Smith, Karen L., Catherine John, Elizabeth I. Sypek, et al.. (2014). Exploring the Role of Central Astrocytic Glutamate Uptake in Ethanol Reward in Mice. Alcoholism Clinical and Experimental Research. 38(5). 1307–1314. 17 indexed citations

14.

John, Catherine & Paul J. Currie. (2012). N-Arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze. Behavioural Brain Research. 233(2). 382–388. 31 indexed citations

15.

John, Catherine, Karen L. Smith, Ashlee Van’t Veer, et al.. (2012). Blockade of Astrocytic Glutamate Uptake in the Prefrontal Cortex Induces Anhedonia. Neuropsychopharmacology. 37(11). 2467–2475. 108 indexed citations

16.

Smith, Karen L., et al.. (2011). CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy. Psychopharmacology. 215(4). 689–695. 40 indexed citations

17.

Currie, Paul J., et al.. (2011). Anorexigenic action of nitric oxide synthase inhibition in the raphe nuclei. Neuroreport. 22(14). 696–699. 8 indexed citations

18.

Smith, Karen L., et al.. (2011). Re: concerns about the antidepressant-like effects of high-dose ketamine in mice. Psychopharmacology. 215(4). 1 indexed citations

19.

Currie, Paul J., et al.. (2010). Hypothalamic paraventricular 5-hydroxytryptamine inhibits the effects of ghrelin on eating and energy substrate utilization. Pharmacology Biochemistry and Behavior. 97(1). 152–155. 38 indexed citations

20.

Currie, Paul J., et al.. (2008). 5-HT1A receptor agonism alters the orexigenic and anxiogenic activity of ghrelin. Appetite. 51(2). 360–360. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact